# HLN catalysts: Haleon plc PDUFA dates and FDA events

Canonical: https://sec-api.dev/companies/hln/catalysts

> Haleon plc (HLN) has no upcoming catalysts in this calendar. The latest recorded is the stannous fluoride and potassium nitrate dentifrice topline data readout, Aug to Nov 2026.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day, quarter only.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Company

| Field | Value |
| --- | --- |
| Name | Haleon plc |
| Ticker | HLN (NYSE) |
| SEC CIK | 1900304 |
| SIC | 2844 |
| SEC filings | https://sec-api.dev/companies/hln |

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| February 14, 2020 | [Voltaren Arthritis Pain (diclofenac sodium) label expansion decision](https://sec-api.dev/pdufa/diclofenac) | HLN |  | completed, approved | "NDA022122 SUPPL-14 (Efficacy): submission_status AP, submission_status_date 20200214, review_priority STANDARD; sponsor_name HALEON US HOLDINGS; product VOLTAREN ARTHRITIS PAIN (DICLOFENAC SODIUM)." ([openFDA Drugs@FDA](https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA022122%22)) |
| February 28, 2020 | [Advil Dual Action With Acetaminophen (acetaminophen; ibuprofen) FDA approval](https://sec-api.dev/pdufa/acetaminophen-ibuprofen) | HLN |  | completed, approved | "NDA211733 ORIG-1 (Type 4 - New Combination): submission_status AP, submission_status_date 20200228, review_priority STANDARD; sponsor_name HALEON US HOLDINGS; product ADVIL DUAL ACTION WITH ACETAMINOPHEN (ACETAMINOPHEN; IBUPROFEN)." ([openFDA Drugs@FDA](https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA211733%22)) |
| September 6, 2025 | [Eno lime primary completion](https://sec-api.dev/pdufa/eno-lime) | HLN | Indigestion Acid; Indigestion; Nausea | completed | "NCT07140341 (A Clinical Study to Assess the Effectiveness of ENO Lime in Participants With Ajeerna Vyadhi (Acidity, Acid Indigestion, Indigestion, and Associated Nausea)): Overall Status COMPLETED; Phase PHASE3; Primary Completion 2025-09-06 (ACTUAL); Lead Sponsor HALEON." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT07140341)) |
| August 11, 2026 | [Stannous fluoride and potassium nitrate dentifrice primary completion](https://sec-api.dev/pdufa/stannous-fluoride-and-nitrate-dentifrice) | HLN | Dentin Hypersensitivity | completed | "NCT07215767 (Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice): Overall Status COMPLETED; Phase PHASE3; Primary Completion 2026-08-11 (ACTUAL); Lead Sponsor HALEON." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT07215767)) |
| Aug to Nov 2026 | [Stannous fluoride and potassium nitrate dentifrice topline data readout](https://sec-api.dev/pdufa/stannous-fluoride-and-nitrate-dentifrice) | HLN | Dentin Hypersensitivity | scheduled | "NCT07215767 (Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice): Overall Status COMPLETED; Phase PHASE3; Primary Completion 2026-08-11 (ACTUAL); Lead Sponsor HALEON." ([ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT07215767)) |

## Drugs

- [Advil Dual Action With Acetaminophen (acetaminophen; ibuprofen)](https://sec-api.dev/pdufa/acetaminophen-ibuprofen): 
- [Voltaren Arthritis Pain (diclofenac sodium)](https://sec-api.dev/pdufa/diclofenac): 
- [Eno lime](https://sec-api.dev/pdufa/eno-lime): Indigestion Acid
- [Stannous fluoride and potassium nitrate dentifrice](https://sec-api.dev/pdufa/stannous-fluoride-and-nitrate-dentifrice): Dentin Hypersensitivity

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/companies/hln/catalysts.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "HLN catalysts: Haleon plc PDUFA dates and FDA events." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/companies/hln/catalysts

```bibtex
@misc{secapidev_companies_hln_catalysts_20261116,
  title        = {HLN catalysts: Haleon plc PDUFA dates and FDA events},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/companies/hln/catalysts}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_companies_hln_catalysts_20261116","title":"HLN catalysts: Haleon plc PDUFA dates and FDA events","publisher":"sec-api.dev","URL":"https://sec-api.dev/companies/hln/catalysts","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
